Cytosolic phosphoenolpyruvate carboxykinase is expressed in α‐cells from human and murine pancreas

The pancreatic islets of Langerhans, mainly formed by glucagon‐producing α‐cells and insulin‐producing β‐cells, are critical for glucose homeostasis. Insulin and glucagon oppositely modulate blood glucose levels in health, but a combined decline in insulin secretion together with increased glucagon secretion contribute to hyperglycemia in diabetes. Despite this bi‐hormonal dysregulation, most studies have focused on insulin secretion and much less is known about glucagon secretion. Therefore, a deeper understanding of α‐cell metabolism and glucagon secretion is of great interest. Here, we show that phosphoenolpyruvate carboxykinase (PCK1), an essential cataplerotic enzyme involved in metabolism and long considered to be absent from the pancreatic islet, is expressed in pancreatic α‐cells of both murine and human. Furthermore, PCK1 transcription is induced by fasting and diabetes in rat pancreas, which indicates that the PCK1 activity is required for α‐cell adaptation to different metabolic states. To our knowledge, this is the first evidence implicating PCK1 expression in α‐cell metabolism. Phosphoenolpyruvate carboxykinase (PCK1) is expressed in the pancreas, specifically in glucagon‐producing alpha‐cells. PCK1 transcription is induced during fasting and diabetes in the pancreas. The data suggest that induction of PCK1 expression in alpha‐cells during fasting and diabetes modulates alpha‐cell metabolism and glucagon secretion.